| Common Stock, Shares, Issued |
17,351,005 |
shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$11,713,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$33,096,000 |
USD |
159% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$187,000 |
USD |
-68% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$254,358,000 |
USD |
-5.3% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$264,053,000 |
USD |
-5.7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$1,965,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$514,000 |
USD |
181% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$28,651,000 |
USD |
-1046% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$2,870,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Property, Plant and Equipment, Gross |
$20,768,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$627,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$608,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$595,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.09 |
pure |
|
Q2 2025 |
Q2 2025 |
| Deferred Income Tax Expense (Benefit) |
$9,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$905,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$551,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$216,296,000 |
USD |
-3.5% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$5,752,000 |
USD |
3.6% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$487,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Depreciation, Depletion and Amortization |
$172,000 |
USD |
-24% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$9,695,000 |
USD |
-16% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$221,000 |
USD |
-58% |
Q3 2025 |
Q3 2025 |